Abstract
Oxidative stress occurs when xenobiotic metabolic reactive intermediates such as reactive oxygen species or free radicals are neither readily detoxified by detoxification enzymes nor compensated for by the body’s antioxidant defense systems. Enzyme modulators are small molecules that exhibit induction or inhibition effects on activation or detoxification enzymes. The induction or inhibition of metabolic enzymes is an issue of complexity. Minimal xenobiotic toxicity is generally found in either a higher expression of detoxification enzyme activity or a fine balance rate between activation and detoxification expressions. Inducers of detoxification enzymes act as indirect antioxidants by boosting the body’s antioxidant systems, thus exerting antioxidant activities. Roles of Nrf2 and ARE on enzyme modulation and lifestyle modulation of metabolic enzymes are also discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Buetler TM, Gallagher EP, Wang C (1995) Induction of phase I and phase II drug metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 135:45–57
Chen CH (2012) Activation and detoxification enzymes: functions and implications. Springer Sciences, New York
Conney AH (2003) Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture. Cancer Res 63:7005–7031
Cuendet M, Oteham CP, Moon RC et al (2006) Quinone reductase induction as a biomarker for cancer chemoprevention. J Nat Prod 69:460–463
Dinkova-Kostova AT, Talalay P (2008) Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52(Suppl l):S128–S138
Finley JW (2003) The antioxidant responsive element (ARE) may explain the protective effects of cruciferous vegetables on cancer. Nutr Rev 61:250–254
Hodges RE, Minich DM (2015) Modulation of metabolic detoxification pathways using foods and food-derived components: a scientific review with clinical application. J Nutr Metab 2015:760689
Jakel RJ, Townsend JA, Kraft AD, Johnson JA (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 1144:192–201
Kensler TW, Curphey TJ, Maxiutenko Y et al (2000) Chemoprotection by organosulfur inducer of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol Drug Interact 17(1–4):3–22
Liu Y, Kern JT, Walker JR et al (2007) A genomic screen for activators of the antioxidant response element. Proc Natl Acad Sci 104:5205–5210
Manson MM, Ball HW, Barrett MC et al (1997) Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B I metabolism. Carcinogenesis 18:1729–1738
Murphy SE, Nunes MG, Hatala MA (1997) Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(metIlylnitrosamino)-I-(3pyridyl)-I-butanone, NNK. Chem Biol Interact 103:153–166
Murray M (2006) Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab 7:67–81
Nguyen T, Sherratt PJ, Pickett CB (2002) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233–260
Okey AB, Roberts EA, Harper PA et al (1986) Induction of drug-metabolizing enzymes: mechanisms and consequences. Clin Biochem 19:132–141
Prochaska HJ, TaJalay P (1998) Regulatory mechanisms ofmonofunctionaJ and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48:4776–4782
Prochaska HJ, Santamaria AB, Talalay P (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci 89:2394–2398
Ramos-Gomez M, Kwak MK, Dolan PM et al (2001) Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci 98:3410–3415
Shen G, Kong AN (2009) Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 30:345–355
Talalay P (1989) Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv Enzyme Regul 28:237–250
Talalay P, Dinkova-Kostova AT, Holtzclaw WD (2003) Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 43:121–134
Wu L, Noyan Ashraf MH, Facci M et al (2004) Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci 101:7094–7099
Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 36:425–438
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, CH. (2020). Induction of Metabolic Enzymes for Health Effects. In: Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense. Springer, Cham. https://doi.org/10.1007/978-3-030-41679-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-41679-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41678-2
Online ISBN: 978-3-030-41679-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)